The level of activity of avermectin B O-methyltransferase, the enzyme which catalyzes the conversion of avermectin B components to avermectin A components, was analyzed in a series of "Streptomyces avermitilis" mutants selected for increased production of the avermectins. In all of the mutants, increased avermectin production was accompanied by increased avermectin B O-methyltransferase activity. Both the average specific activity and the maximum observed specific activity of avermectin B O-methyltransferase increased in direct proportion to avermectin production. The level of avermectin B O-methyltransferase alone did not determine the extent of conversion of avermectin B components to avermectin A components, since a constant ratio of B components to A components was maintained throughout the fermentation even though avermectin B O-methyltransferase specific activity varied three-to fivefold. These results indicate that avermectin B O-methyltransferase is not rate limiting. The correlation between avermectin B O-methyltransferase specific activity and avermectin production is compatible with the hypothesis that genes coding for successive steps in the same secondary metabolite biosynthetic pathway are coordinately regulated.
"Streptomyces avermitilis" produces a number of potent anthelmintic and insecticidal agents known as avermectins (4) . These are a group of structurally related oleandrose disaccharide derivatives of pentacyclic 16-membered lactones (1, 2, 6, 10) . "S. avermitilis" normally produces eight major avermectin components (Fig. 1 ). Approximately 60% of the avermectins have a hydroxyl group attached to C5 and are termed B components, while the remaining 40% have a methoxyl group attached to C5 and are termed A components. The conversion of avermectin B components to avermectin A components is catalyzed by the enzyme avermectin B O-methyltransferase, which transfers the methyl of S-adenosylmethionine (SAM) to the C5 hydroxyl of an avermectin B component to yield an avermectin A component and S-adenosylhomocysteine ( Fig. 2 ) (M. D. Schulman, D. Valentino, and C. Ruby, Fed. Proc. 44:931, 1985) .
Avermectin B O-methyltransferase is the only enzyme involved in avermectin biosynthesis that has been described to date. Recent reports have demonstrated the existence of true operons in S. coelicolor (9) and have indicated a strong tendency for the genes coding for successive steps in the same antibiotic biosynthetic pathway to be contiguous with each other (5) (D. Hopwood, Proc. 6th Int. Symp. Biol. Actinomyces, 1985) . These findings suggest that the enzymes of a biosynthetic pathway may also be coordinately expressed.
We have consequently determined avermectin B 0-methyltransferase activity in a number of strains of "S. avermitilis" with diverse yields of the avermectins to determine if there is any correlation between enzyme activity and avermectin titer. In this paper we report the results of these studies, which demonstrate a direct correlation between * Corresponding author.
increased avermectin production and increased avermectin B O-methyltransferase specific activity in these strains.
MATERIALS AND METHODS Bacterial strains. "S. avermitilis" A is a stable spontaneous mutant of "S. avermitilis" MA4848. Mutants B, C, and D were derived from "S. avermitilis" A by a series of mutagenic steps involving UV light and N-methyl-N-nitrosourethan treatment. For UV light mutagenesis, spores were suspended in sterile dionized water and irradiated at 24 ergs/min per cm2 for 1 min. This resulted in a 95% loss of viability. For mutagenesis with N-methyl-N-nitrosourethan, spores suspended in 10 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES) buffer (pH 7.4) were treated with 1% N-methyl-N-nitrosourethan dissolved in the same buffer for 90 min; a 99% loss of viability resulted. Spore suspensions were agitated during mutagenesis to prevent clumping.
After the mutagenic treatment, spores were plated on agar medium which contained the following: yeast extract (Difco Laboratories), 4 g/liter; malt extract (Difco), 10 29, 1986 on November 6, 2017 by guest http://aac.asm.org/ Downloaded from extracted by shaking the mixture vigorously in an Eberbach reciprocal shaker. After phase separation, 1.5 ml of ethyl acetate was removed and evaporated to dryness. The residue was dissolved in 0.1 ml of methanol, and 20-to 40-ml samples were applied to silica gel-60 F-254-precoated thinlayer chromatography plates (20 by 20 cm, 0.25 mm thick; E. M. Laboratories). The plates were developed in methylene chloride-ethyl acetate (85:15, vol/vol) for 1 to 1.5 h to separate the substrates SAM (Rf = 0) and avermectin B2a aglycone (Rf = 0.29) from the product avermectin A2a aglycone (Rf = 0.48). 14C incorporated in avermectin A2a aglycone was detected by using a Bioscan system 200 (Bioscan, Inc.) coupled to a Hewlett-Packard 85B computer. The assay can detect as little as 20 pmol of product. If increased sensitivity is needed, [methyl-14C]SAM with a higher specific activity can be used.
Analysis and determination of avermectins. Samples of the fermentation broth (2 ml) were brought to 80% saturation with methanol (vol/vol) and shaken vigorously for 15 min in an Eberbach reciprocal shaker. The solids were removed by centrifugation, and avermectin in the supernatant was determined by high-pressure liquid chromatography on a Du Pont Zorbax C-18 column (4.6 by 25 cm) at 60°C with methanolwater (85:15, vol/vol) as the mobile phase (6) . The elution volumes (in milliliters) of the eight major components in order of elution were as follows: B2b, 6.51; B2aa, 7.43; A2b, 8.50; A2a, 9.47; B1b, 10.26; B1a, 12.26; A1b, 13.36; and A1a, 16.20. The A247 was monitored. The sensitivity was 1 ,ug/ml when a 10-,um titer flow cell was used.
Other assays. Protein was determined by the microbiuret method described by Zamenhoff (11) . Avermectin B O-methyltransferase activity in avermectinproducing strains of "S. avermitilis." The time course of avermectin production and the activity of avermectin B 0-methyltransferase in cell-free extracts of several mutants of "S. avermitilis" are shown in Fig. 4 . In all mutants, avermectin synthesis began at approximately 48 h and continued through 144 h. Avermectin B 0-methyltransferase activity in strains A, B, and C appeared between 48 and 72 h, peaked at 120 h, and then decreased. Enzyme activity in strain D followed a different time course; substantial activity was evident at 48 h and increased continuously throughout the fermentation. In other experiments, peak activity for strain D was observed at 144 to 168 h (data not shown).
Comparisons of the average specific activity of avermectin B 0-methyltransferase (48 to 144 h), the maximum observed specific activity of the 0-methyltransferase, and the avermectin titers of the four strains are shown in Table 1 .
The results demonstrated that both the average specific activity and the maximum specific activity of avermectin B 0-methyltransferase increased in direct proportion to the amount of avermectin formed. (8) .
DISCUSSION
In conclusion, avermectin B 0-methyltransferase specific activity has been shown to increase in direct proportion to avermectin production. The close correlation between the specific activity of this enzyme, which is not rate limiting, and avermectin production is compatible with the hypothesis that genes coding for enzymes involved in the biosynthesis of secondary metabolites may be coordinately expressed.
